Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of open-label placebo on pain, functional disability, and spine mobility in patients with chronic back pain: a randomized controlled trial
Julian Kleine‐Borgmann, Katharina Schmidt, Andreas Hellmann, et al.
Pain (2019) Vol. 160, Iss. 12, pp. 2891-2897
Closed Access | Times Cited: 94

Showing 26-50 of 94 citing articles:

Expectancies and avoidance: Towards an integrated model of chronic somatic symptoms
Putu Gita Nadinda, Antoinette I. M. van Laarhoven, Omer Van den Bergh, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 164, pp. 105808-105808
Open Access | Times Cited: 2
Open-Label Placebo Treatment: Outcome Expectations and General Acceptance in the Lay Population
Julia W. Haas, Winfried Rief, Bettina K. Doering
International Journal of Behavioral Medicine (2020) Vol. 28, Iss. 4, pp. 444-454
Open Access | Times Cited: 18
Open-Label Placebo Trial among Japanese Patients with Chronic Low Back Pain
Tatsunori Ikemoto, Takefumi Ueno, Young‐Chang P. Arai, et al.
Pain Research and Management (2020) Vol. 2020, pp. 1-8
Open Access | Times Cited: 18
No long-term effects after a 3-week open-label placebo treatment for chronic low back pain: a 3-year follow-up of a randomized controlled trial
Julian Kleine‐Borgmann, Tim-Niklas Dietz, Katharina Schmidt, et al.
Pain (2022) Vol. 164, Iss. 3, pp. 645-652
Open Access | Times Cited: 12
No open-label placebo effect in insomnia? Lessons learned from an experimental trial
Julia W. Haas, Alexander W. Winkler, Julia Rheker, et al.
Journal of Psychosomatic Research (2022) Vol. 158, pp. 110923-110923
Closed Access | Times Cited: 11
Time to reflect on open-label placebos and their value for clinical practice
Caitlin Jones, Chung‐Wei Christine Lin, Charlotte Blease, et al.
Pain (2023) Vol. 164, Iss. 10, pp. 2139-2142
Closed Access | Times Cited: 6
Can placebos reduce intrusive memories?
Tobias Kube, Irving Kirsch, Julia A. Glombiewski, et al.
Behaviour Research and Therapy (2022) Vol. 158, pp. 104197-104197
Closed Access | Times Cited: 10
Assessing the Impact of Expectations in Cognitive Training and Beyond
Sylvie Denkinger, Lauren Spano, Ulrike Bingel, et al.
Journal of Cognitive Enhancement (2021) Vol. 5, Iss. 4, pp. 502-518
Closed Access | Times Cited: 14
Lay perspectives of the open-label placebo rationale: a qualitative study of participants in an experimental trial
Cosima Locher, Sarah Buergler, Antje Frey Nascimento, et al.
BMJ Open (2021) Vol. 11, Iss. 8, pp. e053346-e053346
Open Access | Times Cited: 14
Effects of Patients’ Expectation in Dermatology: Evidence from Experimental and Clinical Placebo Studies and Implications for Dermatologic Practice and Research
Wiebke Sondermann, Finja Jockenhöfer, Joachim Dissemond, et al.
Dermatology (2021) Vol. 237, Iss. 6, pp. 857-871
Open Access | Times Cited: 13
The beneficial effect of positive treatment expectations on pharmacological migraine prophylaxis
Katharina Schmidt, Tobias Berding, Julian Kleine‐Borgmann, et al.
Pain (2021) Vol. 163, Iss. 2, pp. e319-e327
Closed Access | Times Cited: 13
Paracetamol for low back pain: the state of the research field
Bart W. Koes, Marco Schreijenberg, Alexander Tkachev
Expert Review of Clinical Pharmacology (2020) Vol. 13, Iss. 9, pp. 1059-1066
Open Access | Times Cited: 14
Targeted Use of Placebo Effects Decreases Experimental Itch in Atopic Dermatitis Patients: A Randomized Controlled Trial
Ariane Sölle, Margitta Worm, Fabrizio Benedetti, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 110, Iss. 2, pp. 486-497
Open Access | Times Cited: 12
Open-Label Placebo Administration Decreases Pain in Elderly Patients With Symptomatic Knee Osteoarthritis – A Randomized Controlled Trial
Elisabeth Olliges, Sabine Stroppe, Anja Haile, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 8
“Let’s see what happens:”—Women’s experiences of open-label placebo treatment for menopausal hot flushes in a randomized controlled trial
Yiqi Pan, Miriam L. Frank, Ted J. Kaptchuk, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0276499-e0276499
Open Access | Times Cited: 8
Validating a biosignature-predicting placebo pill response in chronic pain in the settings of a randomized controlled trial
Étienne Vachon‐Presseau, Taha Abdullah, Sara Berger, et al.
Pain (2021) Vol. 163, Iss. 5, pp. 910-922
Open Access | Times Cited: 11
Efficacy of open‐label counterconditioning for reducing nocebo effects on pressure pain
Simone Meijer, Merve Karacaoglu, Henriët van Middendorp, et al.
European Journal of Pain (2023) Vol. 27, Iss. 7, pp. 831-847
Open Access | Times Cited: 4
Open-label placebo treatment does not enhance cognitive abilities in healthy volunteers
Helena Hartmann, Katarina Forkmann, Katharina Schmidt, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
The Ethics of Placebo
Meng-Chen Wu, A. Jon Stoessl
Anesthesiology Clinics (2024) Vol. 42, Iss. 4, pp. 631-645
Closed Access | Times Cited: 1
High-dose biotin in multiple sclerosis: the end of the road
Jeremias Motte, Ralf Gold
The Lancet Neurology (2020) Vol. 19, Iss. 12, pp. 965-966
Closed Access | Times Cited: 11
Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission
Alan R. Prossin, Alisa E. Koch, Phillip L. Campbell, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 2, pp. 831-839
Open Access | Times Cited: 10
Open-Label Placebo Treatment for Experimental Pain: A Randomized-Controlled Trial with Placebo Acupuncture and Placebo Pills
Seoyoung Lee, Dha-Hyun Choi, Minyoung Hong, et al.
Journal of Integrative and Complementary Medicine (2022) Vol. 28, Iss. 2, pp. 136-145
Closed Access | Times Cited: 7
Open-label placebos as adjunctive therapy for patients with depression
Anne Schienle, Nina Jurinec
Contemporary Clinical Trials Communications (2022) Vol. 28, pp. 100948-100948
Open Access | Times Cited: 7
Remotely Provided Open-Label Placebo Reduces Frequency of and Impairment by Allergic Symptoms
Tobias Kube, Irving Kirsch, Julia A. Glombiewski, et al.
Psychosomatic Medicine (2022) Vol. 84, Iss. 9, pp. 997-1005
Open Access | Times Cited: 7
A Conversation with … Ted J. Kaptchuk, Expert in Placebo Effects
Seth S. Leopold
Clinical Orthopaedics and Related Research (2021) Vol. 479, Iss. 8, pp. 1645-1650
Open Access | Times Cited: 9

Scroll to top